Litigation Status
Where this docket stands today
Federal Zantac MDL claims (MDL 2924) were largely dismissed in December 2022 when the MDL court excluded the plaintiffs' general causation experts under Daubert. That ruling effectively ended federal consolidated litigation. State court cases continue in several jurisdictions — notably Delaware (consolidated in the Delaware Superior Court), California (JCCP 5150), and Illinois. This docket is only viable in those active state court forums. Contact us to confirm current availability before committing to volume on this docket.
Docket-Specific Pre-Screen
What we confirm before every Zantac lead is delivered
- Zantac or ranitidine use confirmed — brand or generic version.
- Duration of use documented — regular use over an extended period.
- Qualifying cancer diagnosis — bladder, colorectal, esophageal, stomach, liver, or pancreatic cancer.
- State court jurisdiction confirmed as one of the active Zantac forums — Delaware, California, or Illinois.
- Use period correlates with the NDMA contamination timeline.
- Not part of the dismissed federal MDL.
- Not currently represented — confirmed before the lead leaves our system.
- Treating oncologist or medical records referenced at pre-screen.
The Market
The Zantac market
Zantac (ranitidine) was recalled in 2020 after the FDA identified that ranitidine can form NDMA — a probable human carcinogen — at elevated temperatures and during storage. Claims emerged alleging that long-term Zantac use caused various cancers through NDMA exposure. The federal MDL (2924) was filed in the Southern District of Florida and grew to tens of thousands of cases.
In December 2022, Judge Robin Rosenberg excluded the plaintiffs' general causation experts under Daubert after extensive evidentiary hearings, effectively ending the federal consolidated litigation. That ruling did not bind state courts, and active Zantac litigation continues in Delaware, California, and Illinois state court systems with different procedural frameworks and expert evidence standards.
This docket is only viable for claims that can be filed in one of the active state court jurisdictions. Our pre-screen confirms the claimant's state and the applicable forum before delivery.
Docket Pipeline
How Zantac leads are qualified
Targeted Acquisition
Only people who matched your exact criteria submitted a form.
Form Pre-Screen
SOL, liability, insurance, and intent — all confirmed before delivery.
OTP Phone Verification
The number is real. We proved it before you see it.
Exclusive Delivery
Your CRM. One firm. In under 15 seconds.
Pricing is per qualified lead — never a retainer, never a setup fee, never a monthly commitment. Calculate your all-in cost per signed retainer before you book the call.
Delivery Standards
How every lead arrives and what stands behind it
Every lead passes through four verification steps before delivery. Targeted acquisition drives intake traffic only from people who match your stated criteria. The form pre-screen documents SOL, liability, injury severity, and representation status. OTP phone verification confirms the number is real, active, and in possession of the claimant — not Google Voice, not a disconnected line, not a wrong number. Exclusive delivery places the lead into your CRM inside 15 seconds, locked to your firm ID with a permanent delivery timestamp.
Exclusivity is contractual, not verbal. Your client agreement contains a binding exclusivity term — every lead is sold to exactly one firm and there is no operational path for us to re-deliver it. TrustedForm certificates and Jornaya lead IDs travel with every lead as an independent consent audit trail, timestamped outside our own delivery system. The 48-hour credit exchange is written into your agreement as a contract term, not a return policy: expired SOL at delivery, liability that clearly does not hold based on pre-screen facts, case type mismatch, or represented-at-delivery all qualify without additional documentation. Your intake team’s assessment is sufficient.
Coverage runs in 38 states. Pricing is per qualified lead — no retainer, no setup fee, no monthly commitment. Volume can be paused or reduced with 30 days notice without penalty. Auto-connect puts your intake team on the phone with the claimant within 60 seconds of delivery, which is the single largest lever on contact-to-signed-retainer conversion in every vendor benchmark we have run. Firms routinely report 18–23% close rates on identical leads simply by moving first-call contact from 5 minutes to 60 seconds.
Read the full pipeline breakdown for operational detail on each verification step, or run your numbers with the cost-per-retainer calculator before booking a call.
Frequently Asked Questions
- Federal MDL claims are effectively closed after the December 2022 Daubert exclusion. State court cases continue in Delaware (consolidated in Delaware Superior Court), California (JCCP 5150), and Illinois. The docket is only viable for claims that can be filed in one of these active state court forums.
Related dockets
The Arrangement
No retainer. No setup fee. No monthly commitment.
Start receiving verified leads in 5–7 days. One firm per case. Every lead OTP-verified. Credit exchange written into your client agreement.